2015
DOI: 10.1016/j.ecl.2015.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Primary Aldosteronism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0
3

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 93 publications
0
5
0
3
Order By: Relevance
“…However, hypokalemia is not a sensitive marker of PA, as only a 9–37% overall incidence of hypokalemia has been reported in PA patients (22, 23). Secondly, many factors may disturb ARR, including volume status, age, potassium, time of day and antihypertensive use (24). Facing these problems, the absolute aldosterone levels are also taken into account when measuring ARR.…”
Section: Discussionmentioning
confidence: 99%
“…However, hypokalemia is not a sensitive marker of PA, as only a 9–37% overall incidence of hypokalemia has been reported in PA patients (22, 23). Secondly, many factors may disturb ARR, including volume status, age, potassium, time of day and antihypertensive use (24). Facing these problems, the absolute aldosterone levels are also taken into account when measuring ARR.…”
Section: Discussionmentioning
confidence: 99%
“…However, the differential diagnosis between APA and CPA still remains challenging because many patients are asymptomatic or there were only non-specific symptoms with no clinical evidence of steroid overproduction ( 2 , 3 ). The gold standard for the diagnosis of APA is through a technically difficult and invasive procedure that samples from a vein located near the adrenal glands, called adrenal vein sampling (AVS), to determine aldosterone and cortisol levels ( 4 , 5 ) The success rate of right AVS is as low as 10% because of the particular and complex anatomical structure ( 6 ). Moreover, about 10–20% of ACAs are bilateral or multiple ( 7 , 8 ).…”
Section: Introductionmentioning
confidence: 99%
“…Primary aldosteronism (PA) and Cushing’s syndrome (CS) are usually caused by autonomous over-secretion of aldosterone or cortisol, from the corresponding adrenal zones as a result of hyperplasia or tumors. Both overt and subclinical PA and CS have long-term adverse effects on multiple organs [2, 3]. Patients with concurrent hypersecretion of cortisol and aldosterone have been previously reported, and it is difficult to make the correct diagnosis in those patients [48], however, most of these patients had adenomas that secreted both cortisol and aldosterone simultaneously, i.e.…”
Section: Introductionmentioning
confidence: 99%